Topic 07 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 49 - 15 Topics

cite ad title authors publish year publish time dataset abstract mentions covid pmcid pubmed id doi cord uid topic weight Similarity scispacy Similarity specter
1 Liumbruno_2014 Solvent/detergent plasma: pharmaceutical characteristics and clinical experience Liumbruno, Giancarlo Maria; Franchini, Massimo 2014 2014-05-21 PMC N PMC7088539 24844804.0 10.1007/s11239-014-1086-1 5lnt5sp4 0.955171 Burnouf_2007
2 Klamroth_2013 Pathogen inactivation and removal methods for plasma‐derived clotting factor concentrates Klamroth, Robert; Gröner, Albrecht; Simon, Toby L. 2013 2013-09-30 PMC N PMC7169823 24117799.0 10.1111/trf.12423 0jgw083h 0.945977
3 Kempf_2007 Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulins Kempf, Christoph; Stucki, Martin; Boschetti, Nicola 2007 2007-03-31 PMC N PMC7129354 16581263.0 10.1016/j.biologicals.2006.01.002 y1d0leic 0.913792
4 Caricati_2013 Safety of snake antivenom immunoglobulins: Efficacy of viral inactivation in a complete downstream process Caricati, C. P.; Oliveira‐Nascimento, L.; Yoshida, J. T.; Stephano, M. A.; Caricati, A. T. P.; Raw, I. 2013 2013-06-27 PMC N PMC7161767 23804299.0 10.1002/btpr.1758 oxfnt2n4 0.835939
5 Burnouf_2014 “Go no Go” in plasma fractionation in the world's emerging economies: Still a question asked 70 years after the COHN process was developed! Burnouf, Thierry; Seghatchian, Jerard 2014 2014-10-31 PMC N PMC7106424 25457750.0 10.1016/j.transci.2014.10.002 pc98lbg6 0.828307 Burnouf_2007
6 Burnouf_2007 Modern Plasma Fractionation Burnouf, Thierry 2007 2007-04-30 PMC N PMC7125842 17397761.0 10.1016/j.tmrv.2006.11.001 s8rxzm0t 0.801673 Burnouf_2004
7 Vaughn_1984 Public health considerations associated with molluscan aquaculture systems: Human viruses Vaughn, James M.; Landry, Edward F. 1984 1984-06-15 PMC N 10.1016/0044-8486(84)90273-4 d1r504zx 0.767826
8 Gröner_2017 Effective inactivation of a wide range of viruses by pasteurization Gröner, Albrecht; Broumis, Connie; Fang, Randel; Nowak, Thomas; Popp, Birgit; Schäfer, Wolfram; Roth, Nathan J. 2017 2017-11-16 NONCOMM N PMC7169671 29148053.0 10.1111/trf.14390 w19hl2vs 0.758510
9 Burnouf_2004 Assessment of the viral safety of antivenoms fractionated from equine plasma Burnouf, Thierry; Griffiths, Elwyn; Padilla, Ana; Seddik, Salwa; Stephano, Marco Antonio; Gutiérrez, José-María 2004 2004-09-30 PMC N PMC7128792 15536042.0 10.1016/j.biologicals.2004.07.001 6k7tcgfs 0.718500
10 Maes_2007 Evaluation of the efficacy of disinfectants against Puumala hantavirus by real-time RT-PCR Maes, Piet; Li, Sandra; Verbeeck, Jannick; Keyaerts, Els; Clement, Jan; Van Ranst, Marc 2007 2007-04-30 PMC N 17188760.0 10.1016/j.jviromet.2006.11.037 ggytzpqy 0.707638
11 Heldt_2008 Identification of Trimeric Peptides That Bind Porcine Parvovirus from Mixtures Containing Human Blood Plasma Heldt, Caryn L.; Gurgel, Patrick V.; Jaykus, Lee‐Ann; Carbonell, Ruben G. 2008 2008-09-05 PMC N PMC7161850 18470993.0 10.1021/bp070412c h55l3lvp 0.703797
12 Valdés_2002 Chromatographic removal combined with heat, acid and chaotropic inactivation of four model viruses Valdés, R; Ibarra, Neysi; Ruibal, I; Beldarraı́n, A; Noa, E; Herrera, N; Alemán, R; Padilla, S; Garcia, J; Pérez, M; Morales, R; Chong, E; Reyes, B; Quiñones, Y; Agraz, A; Herrera, L 2002 2002-07-03 PMC N PMC7126170 12044553.0 10.1016/s0168-1656(02)00047-0 pzc4ivvg 0.678695
13 Rabenau_2005 SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D) treated immunoglobulin preparation Rabenau, H.F.; Biesert, L.; Schmidt, T.; Bauer, G.; Cinatl, J.; Doerr, H.W. 2005 2005-06-30 PMC N PMC7128630 15939287.0 10.1016/j.biologicals.2005.01.003 hdkmwihu 0.634846
14 Junter_2020 Polysaccharide-based chromatographic adsorbents for virus purification and viral clearance Junter, Guy-Alain; Lebrun, Laurent 2020 2020-01-13 PMC N 10.1016/j.jpha.2020.01.002 zddwajzg 0.618490
15 Malenovská_2014 The influence of stabilizers and rates of freezing on preserving of structurally different animal viruses during lyophilization and subsequent storage Malenovská, H. 2014 2014-11-04 PMC N PMC7166340 25250638.0 10.1111/jam.12654 iim3akyw 0.523030
16 Fedosyuk_2019 Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components Fedosyuk, Sofiya; Merritt, Thomas; Peralta-Alvarez, Marco Polo; Morris, Susan J; Lam, Ada; Laroudie, Nicolas; Kangokar, Anilkumar; Wright, Daniel; Warimwe, George M; Angell-Manning, Phillip; Ritchie, Adam J; Gilbert, Sarah C; Xenopoulos, Alex; Boumlic, Anissa; Douglas, Alexander D 2019 2019-11-08 None N PMC6949866 31047679.0 10.1016/j.vaccine.2019.04.056 u8y47qmd 0.463697
17 Wolff_2008 Downstream Processing: From Egg to Cell Culture‐Derived Influenza Virus Particles Wolff, M. W.; Reichl, U. 2008 2008-05-27 PMC N PMC7162065 10.1002/ceat.200800118 zx26o1pt 0.443961
18 Yang_2015 Efficient Structure Resonance Energy Transfer from Microwaves to Confined Acoustic Vibrations in Viruses Yang, Szu-Chi; Lin, Huan-Chun; Liu, Tzu-Ming; Lu, Jen-Tang; Hung, Wan-Ting; Huang, Yu-Ru; Tsai, Yi-Chun; Kao, Chuan-Liang; Chen, Shih-Yuan; Sun, Chi-Kuang 2015 2015-12-09 COMM-USE N PMC4673452 26647655.0 10.1038/srep18030 x8tnweih 0.438396 Wu_Y_2014, Wang_2019
19 Thirion_2020 Lyophilized Matrix Containing Ready-to-Use Primers and Probe Solution for Standardization of Real-Time PCR and RT-qPCR Diagnostics in Virology Thirion, Laurence; Dubot-Peres, Audrey; Pezzi, Laura; Corcostegui, Iban; Touinssi, Mhammed; de Lamballerie, Xavier; Charrel, Remi N. 2020 2020-01-30 COMM-USE N PMC7077261 32019076.0 10.3390/v12020159 jkzqmkz6 0.428197
20 Wolf_2014 Downstream processing of cell culture-derived virus particles Wolf, Michael W; Reichl, Udo 2014 2014-01-09 PMC N PMC7103681 21988309.0 10.1586/erv.11.111 dw989txm 0.423567 Vázquez-Ramírez_2019, Vázquez-Ramírez_2018
21 McKeen_2012 1 Introduction to Food Irradiation and Medical Sterilization McKeen, Laurence 2012 2012-12-31 PMC N PMC7151773 10.1016/b978-1-4557-2598-4.00001-0 25qqr3vt 0.403487
22 Yunoki_2004 Heat sensitivity of a SARS‐associated coronavirus introduced into plasma products Yunoki, M.; Urayama, T.; Yamamoto, I.; Abe, S.; Ikuta, K. 2004 2004-12-07 PMC N PMC7169306 15585028.0 10.1111/j.1423-0410.2004.00577.x cr87y1ep 0.396891
23 Wood_1998 The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses Wood, A.; Payne, D. 1998 1998-04-30 PMC N PMC7134397 9602977.0 10.1016/s0195-6701(98)90077-9 0m1ngob3 0.357269
24 Sano_2016 Risk management of viral infectious diseases in wastewater reclamation and reuse: Review Sano, Daisuke; Amarasiri, Mohan; Hata, Akihiko; Watanabe, Toru; Katayama, Hiroyuki 2016 2016-05-31 PMC N PMC7111293 26985655.0 10.1016/j.envint.2016.03.001 b5tduubu 0.342490
25 Junter_2017 Cellulose-based virus-retentive filters: a review Junter, Guy-Alain; Lebrun, Laurent 2017 2017-06-01 PMC N PMC7088658 10.1007/s11157-017-9434-1 gw8mgg4m 0.339553 Yang_2007 Junter_2020
26 Bradley_1985 The agents of non-A, non-B viral hepatitis Bradley, Daniel W. 1985 1985-04-30 PMC N 3923011.0 10.1016/0166-0934(85)90047-3 jznp3n1n 0.315104